Induction of p53-dependent and p53-independent cellular responses by topoisomerase I inhibitors
1998

Effects of Topoisomerase I Inhibitors on Ovarian Cancer Cells

publication Evidence: moderate

Author Information

Author(s): AC McDonald, R Brown

Primary Institution: CRC Department of Medical Oncology, CRC Beatson Laboratories

Hypothesis

How do topoisomerase I inhibitors affect p53-dependent and p53-independent cellular responses in ovarian cancer cells?

Conclusion

Topoisomerase I inhibitors induce both p53-dependent and p53-independent cell death in ovarian cancer cells.

Supporting Evidence

  • Mutant p53 transfectants showed increased resistance to some drugs but not to camptothecin.
  • Topoisomerase I inhibitors induced apoptosis in A2780 cells, which was reduced in mutant p53 transfectants.
  • The study confirmed that p53 status affects apoptosis but not clonogenic survival.

Takeaway

This study shows that certain cancer drugs can kill cancer cells even if a key protein, p53, isn't working properly.

Methodology

The study used human ovarian cancer cell lines to assess drug sensitivity, cell cycle changes, and apoptosis through various assays.

Limitations

The study primarily focuses on in vitro results, which may not fully represent in vivo responses.

Participant Demographics

Human ovarian cancer cell lines (A2780, A2780/mp53, A2780/v)

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication